|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/341 | |
| A61K 9/00 | |||
| A61K 47/02 | |||
| A61K 47/18 | |||
| A61K 9/08 | |||
| A61K 31/635 | |||
| A61P 9/12 | |||
| A61P 9/04 |
| (11) | Number of the document | 2981258 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14778339.3 |
| Date of filing the European patent application | 2014-04-03 | |
| (97) | Date of publication of the European application | 2016-02-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/032800 |
| Date | 2014-04-03 |
| (87) | Number | WO 2014/165660 |
| Date | 2014-10-09 |
| (30) | Number | Date | Country code |
| 201361808962 P | 2013-04-05 | US |
| (72) |
MICHAELS, Scott, A., US
MUNTENDAM, Pieter, US
LARSEN, Glenn, R., US
|
| (73) |
scPharmaceuticals Inc.,
2400 District Avenue, Suite 310, Burlington, MA 01803,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE |
| PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE |